Gliomatosis cerebri epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (21 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gliomatosis cerebri}} | {{Gliomatosis cerebri}} | ||
{{CMG}} | {{CMG}}{{AE}}{{SR}} | ||
==Overview== | ==Overview== | ||
Gliomatosis cerebri is a rare [[brain tumor]]. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States. Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years. The median age at diagnosis is 34 years. Males are more commonly affected with gliomatosis cerebri than females. The male to female ratio is approximately 1.5 to 1. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics == | ||
===Incidence=== | |||
*Gliomatosis cerebri is a rare [[brain tumor]]. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.<ref name="epi"> Gliomatosis cerebri international registry. http://gcregistry.com/</ref> | |||
===Age=== | ===Age=== | ||
* Gliomatosis cerebri | *Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.<ref name="aaa">Epidemiology of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref> | ||
*The median age at diagnosis is 34 years.<ref name="pmid9810441">{{cite journal| author=Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH et al.| title=Gliomatosis cerebri: clinical features, treatment, and prognosis. | journal=Acta Neurochir (Wien) | year= 1998 | volume= 140 | issue= 8 | pages= 755-62 | pmid=9810441 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9810441 }} </ref> | |||
===Gender=== | |||
*Males are slightly more affected than females. The male to female ratio is approximately 1.5 to 1.<ref name="aaa">Epidemiology of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri</ref> | |||
===Incidence=== | |||
*The annual incidence rate of gliomatosis cerebri is approximately 0.1 per 1,000,000 individuals worldwide.<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pubmed/29464663|title=Incidence and survival of gliomatosis cerebri: a population-based cancer registration study|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | |||
===Race=== | |||
*There is no data on racial predilection for gliomatosis cerebri. | |||
===Region=== | |||
*There is no data on regional and geographical predilection for gliomatosis cerebri. | |||
===Developed Countries=== | |||
===Developing Countries=== | |||
==References== | ==References== | ||
| Line 17: | Line 37: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Neurosurgery]] | [[Category:Neurosurgery]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 16:32, 7 October 2019
|
Gliomatosis cerebri Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gliomatosis cerebri epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Gliomatosis cerebri epidemiology and demographics |
|
Gliomatosis cerebri epidemiology and demographics in the news |
|
Risk calculators and risk factors for Gliomatosis cerebri epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States. Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years. The median age at diagnosis is 34 years. Males are more commonly affected with gliomatosis cerebri than females. The male to female ratio is approximately 1.5 to 1.
Epidemiology and Demographics
Incidence
- Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.[1]
Age
- Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.[2]
- The median age at diagnosis is 34 years.[3]
Gender
- Males are slightly more affected than females. The male to female ratio is approximately 1.5 to 1.[2]
Incidence
- The annual incidence rate of gliomatosis cerebri is approximately 0.1 per 1,000,000 individuals worldwide.[4]
Race
- There is no data on racial predilection for gliomatosis cerebri.
Region
- There is no data on regional and geographical predilection for gliomatosis cerebri.
Developed Countries
Developing Countries
References
- ↑ Gliomatosis cerebri international registry. http://gcregistry.com/
- ↑ 2.0 2.1 Epidemiology of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri
- ↑ Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH; et al. (1998). "Gliomatosis cerebri: clinical features, treatment, and prognosis". Acta Neurochir (Wien). 140 (8): 755–62. PMID 9810441.
- ↑ "Incidence and survival of gliomatosis cerebri: a population-based cancer registration study".